This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
321 |
4. Check minimum number of eventsNone |
321 |
5. Include endpointsNone |
321 |
6. Filter based on genotype QC (FinnGen only) |
292 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF7
Similar endpoints
↥List of similar endpoints to
Pyoderma gangrenosum
based on the number of shared cases.
Similar with more cases:
- Other disorders of skin and subcutaneous tissue
- Diseases of the skin and subcutaneous tissue
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 292 | 190 | 102 |
| Unadjusted period prevalence (%) | 0.06 | 0.07 | 0.05 |
| Median age at first event (years) | 58.32 | 56.80 | 61.16 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 306
- Matched controls
- 3060
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L88
ICD-10 Finland
Pyoderma gangrenosum
+∞
307.7
306
*
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
52.2
153.7
92
25
S97
ICPC
Chronic ulcer skin
22.8
149.5
130
96
D07AD01
ATC
clobetasol; topical
15.7
137.6
197
315
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
16.2
126.3
138
148
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
26.6
121.0
91
48
TQW80
NOMESCO Finland
Local dermatologic skincare
39.6
114.6
73
24
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
58.7
113.4
65
14
L04AX01
ATC
azathioprine; systemic
21.1
100.5
83
53
L04AD01
ATC
ciclosporin; systemic
38.9
82.4
52
16
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
14.9
72.3
71
61
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
13.5
69.0
72
68
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
6.8
60.3
206
709
H02AB06
ATC
prednisolone; systemic
9.2
60.0
254
1063
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
13.0
55.6
58
54
SPAT1148
SPAT
Treatment of chronic ulcer or burn
7.0
52.9
104
211
L04AA06
ATC
mycophenolic acid; systemic
19.9
49.8
40
23
A07EC02
ATC
mesalazine; oral, rectal
9.6
47.4
62
79
J01FF01
ATC
clindamycin; systemic
5.0
43.9
162
559
K50.8
ICD-10 Finland
Other Crohn disease
19.6
43.5
35
20
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
13.0
41.3
42
37
A07EA06
ATC
budesonide; oral, local oral
9.9
40.3
50
59
K51.5
ICD-10 Finland
Left sided colitis
11.7
38.6
42
41
L01BA01
ATC
methotrexate; systemic
12.3
38.1
40
37
XQ848
NOMESCO Finland
Dermatological photography
13.4
37.5
37
31
L04AX03
ATC
methotrexate; systemic
6.2
37.2
76
156
TPH07
NOMESCO Finland
Cathetrisation of artery
6.0
35.9
75
157
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
12.6
34.2
35
31
UJF32
NOMESCO Finland
Coloscopy
4.2
33.1
133
471
L04AB04
ATC
adalimumab; parenteral
13.6
32.9
32
26
TPH04
NOMESCO Finland
Cathetrisation of vein
4.3
32.8
119
391
WX302
NOMESCO Finland
Thoracal epidural anesthesy
7.9
31.0
46
67
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
6.2
31.0
60
116
A07EC01
ATC
sulfasalazine; oral, rectal
5.9
30.1
61
123
R4190
NOMESCO Finland
Nutritional therapy
8.8
29.2
39
50
ZZA00
NOMESCO Finland
Split skin graft
11.4
28.5
31
30
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
4.7
28.4
80
214
S18
ICPC
Laceration/cut
3.8
27.7
202
1036
D07AC01
ATC
betamethasone; topical
3.6
27.6
169
775
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
4.7
27.1
76
202
H02AB07
ATC
prednisone; oral
4.5
26.9
80
223
TQW11
NOMESCO Finland
Vacuum treatment of wound
11.3
26.6
29
28
A46
ICD-10 Finland
Erysipelas
4.3
26.6
87
260
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.8
26.6
72
186
J01MA12
ATC
levofloxacin; systemic
4.0
26.4
98
321
J01MA02
ATC
ciprofloxacin; systemic
3.5
25.7
172
824
SPAT1262
SPAT
Handing over of treatment supplies
4.1
25.6
88
272
J01CF05
ATC
flucloxacillin; systemic
5.3
25.6
59
133
L30.9
ICD-10 Finland
Dermatitis, unspecified
3.7
25.6
112
410
H02AB09
ATC
hydrocortisone; systemic
10.9
25.1
28
28
ZX120
NOMESCO Finland
Intravenous
4.9
24.8
63
154
J04BA02
ATC
dapsone; oral
53.2
24.8
29
6
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
23.1
24.5
35
17
K50.9
ICD-10 Finland
Crohn disease, unspecified
23.1
24.5
35
17
E0000UV, ,
ATC
3.4
24.3
188
973
A02BC02
ATC
pantoprazole; systemic
4.7
24.1
258
1638
QXB99, ,
SPAT
10.2
23.9
28
30
N02AA05
ATC
oxycodone; systemic
3.8
23.5
94
322
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
4.4
23.0
68
187
UJF12
NOMESCO Finland
Enteroscopy through intestinal stoma
129.8
22.9
24
*
M05BA04
ATC
alendronic acid; oral
5.1
22.8
53
120
WX402
NOMESCO Finland
General anaesthesia
3.5
22.7
111
432
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
5.6
22.6
47
96
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
6.7
22.6
38
63
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
22.8
21.7
31
15
UJF30
NOMESCO Finland
Ileoscopy through colon
4.2
21.7
67
190
P01AB01
ATC
metronidazole; oral, rectal
3.1
20.9
175
922
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
5.4
20.9
45
95
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.9
20.7
40
76
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.1
20.5
185
1013
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
26.8
19.9
27
11
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.7
19.5
77
258
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.0
18.9
126
578
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
6.4
18.3
32
55
J01DB01
ATC
cefalexin; oral
8.1
18.0
292
2204
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
4.9
18.0
43
99
L95.9
ICD-10 Finland
Vasculitis limited to skin, unspecified
+∞
17.9
17
*
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
6.0
17.8
33
60
K50.1
ICD-10 Finland
Crohn disease of large intestine
18.4
17.7
27
16
OAB50, ,
SPAT
4.3
17.1
49
130
C03CA01
ATC
furosemide; systemic
2.9
16.7
114
524
WX408
NOMESCO Finland
General anesthesy, balanced
2.9
16.5
109
491
R4110
NOMESCO Finland
Physiotherapy
2.8
16.4
117
549
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
7.6
16.3
24
34
ZXE20
NOMESCO Finland
More than three and less than five hours
3.5
16.3
66
223
P01BA02
ATC
hydroxychloroquine; oral
4.2
16.1
48
131
L73.2
ICD-10 Finland
Hidradenitis suppurativa
14.0
16.0
27
21
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
7.1
16.0
25
38
QDB10, ,
SPAT
7.4
15.9
24
35
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
4.4
15.9
43
109
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
5.6
15.9
32
63
L04AA01
ATC
[U] ciclosporin
23.6
15.8
22
10
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
5.5
15.4
31
61
TPH40
NOMESCO Finland
Insertion of a long peripheral venous catheter
26.6
14.9
20
8
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.3
14.8
64
225
N02AX02
ATC
tramadol; systemic, rectal
2.5
14.5
160
920
A10AC01
ATC
insulin (human); parenteral
4.1
14.3
43
118
B01AB05
ATC
enoxaparin; parenteral
2.6
14.2
123
628
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
3.3
14.2
64
230
R50.9
ICD-10 Finland
Fever, unspecified
3.0
14.1
75
297
L88
ICPC
Rheumatoid/seropositive arthritis
5.5
13.9
28
55
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
6.1
13.9
25
44
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
4.1
13.9
41
111
A10AB05
ATC
insulin aspart; parenteral
4.0
13.8
43
121
ZXE10
NOMESCO Finland
More than one and less than three hours
2.5
13.7
139
762
Z93.2
ICD-10 Finland
Ileostomy status
78.7
13.7
15
*
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
6.1
13.4
24
42
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.5
13.3
50
160
ZXE00
NOMESCO Finland
One hour or less
2.4
13.1
147
840
WX002
NOMESCO Finland
Sedation and analgesia
2.8
13.1
82
354
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
29.9
13.1
17
6
D94
ICPC
Chronic enteritis/ulcerative colitis
29.9
13.1
17
6
N03AX16
ATC
[U] pregabalin
2.7
13.1
92
422
JN4AD
NOMESCO Finland
Body CT examination
3.3
13.0
54
184
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
5.5
12.9
26
51
K50.0
ICD-10 Finland
Crohn disease of small intestine
13.1
12.8
22
18
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
6.6
12.6
21
34
D07BC01
ATC
betamethasone and antiseptics; topical
3.3
12.6
53
182
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
4.0
12.6
39
109
JN3AD
NOMESCO Finland
Abdominal CT examination
3.1
12.5
59
217
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
6.2
12.4
22
38
TQW99
NOMESCO Finland
Other minor procedure on skin
4.5
12.4
32
78
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
6.2
12.0
21
36
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.1
11.8
57
213
L08.0
ICD-10 Finland
Pyoderma
31.4
11.8
15
5
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.5
11.7
99
493
L40.0
ICD-10 Finland
Psoriasis vulgaris
5.3
11.7
24
48
L89
ICD-10 Finland
Decubitus ulcer and pressure area
8.9
11.5
24
29
ZXD05
NOMESCO Finland
Urgent procedure
2.4
11.3
117
636
D64.9
ICD-10 Finland
Anaemia, unspecified
3.4
11.3
45
149
TJF80
NOMESCO Finland
Ostomy education
21.0
11.2
16
8
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.8
11.2
37
108
B01AB10
ATC
tinzaparin; parenteral
3.1
11.2
53
195
A07EA02
ATC
hydrocortisone; rectal
9.8
11.2
22
24
K51.3
ICD-10 Finland
Ulcerative (chronic) rectosigmoiditis
9.8
11.2
22
24
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
14.6
11.1
18
13
D07AB02
ATC
hydrocortisone butyrate; topical
2.4
11.1
114
617
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
4.3
11.0
30
76
L04AC05
ATC
ustekinumab; parenteral
45.0
11.0
13
*
SPAT1149
SPAT
Suture or treatment of traumatic wound
3.0
10.9
55
210
D02AX
ATC
Other emollients and protectives
5.6
10.7
21
40
JFG40
NOMESCO Finland
Revision of enterostomy or colostomy without laparotomy
62.2
10.7
12
*
XF600
NOMESCO Finland
Bloodpressure measurement
4.0
10.4
31
84
D07AC13
ATC
mometasone; topical
2.3
10.4
106
569
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.2
10.4
45
157
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.8
10.3
59
241
A28
ICPC
Limited function/disability NOS
2.6
10.3
68
299
L02.9
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle, unspecified
4.6
10.3
25
58
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.1
10.0
44
155
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.8
9.9
57
233
UJF14
NOMESCO Finland
Enteroscopy of ileoanal anastomosis
27.0
9.9
13
5
SPAT1151
SPAT
Treatment of major wounds
20.9
9.9
14
7
N02AJ06
ATC
codeine and paracetamol; systemic
2.2
9.8
155
988
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
3.0
9.8
46
168
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
8.3
9.8
21
27
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
3.3
9.6
38
125
E66.8
ICD-10 Finland
Other obesity
4.0
9.6
28
75
4AA12, ,
NOMESCO Finland
103.1
9.5
10
*
WVA20
NOMESCO Finland
Medicine administration
5.1
9.4
20
41
JFH20
NOMESCO Finland
Proctocolectomy and ileostomy
+∞
9.4
9
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.4
9.4
36
116
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
4.4
9.4
24
58
WX892
NOMESCO Finland
Monitored bed care
3.5
9.4
34
106
S10
ICPC
Boil/carbuncle
3.5
9.3
33
101
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.8
9.3
52
209
Z71.8
ICD-10 Finland
Other specified counselling
2.1
9.2
128
772
XW000
NOMESCO Finland
Bone marrow biopsy
5.0
9.2
20
42
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
3.8
9.2
29
82
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
37.9
9.1
11
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.4
9.1
75
365
JH1CG
NOMESCO Finland
Extensive MRI of perianal area
24.9
9.0
12
5
K51
ICD-10 Finland
Ulcerative colitis
13.1
9.0
15
12
L03.9
ICD-10 Finland
Cellulitis, unspecified
9.0
8.9
18
21
D07XC01
ATC
betamethasone; topical
2.8
8.8
49
196
N02BF02
ATC
pregabalin; oral
3.4
8.8
33
105
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
2.1
8.8
111
643
D09AB01
ATC
zinc bandage without supplements; topical
14.6
8.8
14
10
ZXD10
NOMESCO Finland
Scheduled procedure
2.1
8.8
126
767
Z3231
NOMESCO Finland
Registered nurse
2.2
8.7
97
535
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
3.2
8.7
36
122
QBB10, ,
SPAT
10.5
8.6
16
16
L52
ICD-10 Finland
Erythema nodosum
16.9
8.6
13
8
K92.1
ICD-10 Finland
Melaena
3.8
8.6
27
76
S76
ICPC
Skin infection other
3.5
8.6
31
96
WZC30
NOMESCO Finland
Teaching
2.5
8.6
64
297
D07AB08
ATC
desonide; topical
2.7
8.5
49
200
K08.3
ICD-10 Finland
Retained dental root
3.3
8.4
33
108
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.3
8.4
22
54
L01BB02
ATC
mercaptopurine; oral
11.2
8.4
15
14
JFG50
NOMESCO Finland
Laparotomy with revision of enterostomy or colostomy
+∞
8.4
8
*
R5110, ,
SPAT
3.0
8.4
38
136
J01MA14
ATC
moxifloxacin; systemic
3.0
8.3
40
148
S29
ICPC
Skin symptom/complaint other
2.3
8.3
77
393
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.9
8.3
43
166
O99.6
ICD-10 Finland
Diseases of the digestive system complicating pregnancy, childbirth and the puerperium
34.3
8.1
10
*
L28
ICPC
Limited function/disability (L)
2.3
8.1
69
339
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.2
8.0
83
442
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
4.2
8.0
22
56
K51.8
ICD-10 Finland
Other ulcerative colitis
6.9
8.0
19
29
Z02.7
ICD-10 Finland
Issue of medical certificate
3.1
8.0
36
128
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
2.2
8.0
85
458
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
13.5
7.9
13
10
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.2
7.9
32
107
XF400
NOMESCO Finland
ECG with 12 standard connections
2.5
7.8
56
254
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.6
7.8
49
209
TKC20
NOMESCO Finland
Catheterisation of bladder
3.4
7.8
29
92
JF1DG
NOMESCO Finland
Small bowel very extensive MRI with with high intensity magnet
46.2
7.8
9
*
R06AE07
ATC
cetirizine; oral
2.0
7.8
150
1004
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
4.0
7.7
22
58
L04AB01
ATC
etanercept; parenteral
12.3
7.6
13
11
QBA10
NOMESCO Finland
Incision of skin of trunk
12.3
7.6
13
11
S31.1
ICD-10 Finland
Open wound of abdominal wall
25.7
7.6
10
*
E000001, ,
ATC
2.2
7.6
75
391
WZC00
NOMESCO Finland
Treatment plan or consultation
2.0
7.6
124
781
A41.9
ICD-10 Finland
Sepsis, unspecified
4.4
7.6
19
45
A10AE04
ATC
insulin glargine; parenteral
2.8
7.5
40
156
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
4.6
7.5
18
41
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
8.0
7.5
16
21
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
8.0
7.5
16
21
L04AA13
ATC
[U] leflunomide
8.0
7.5
16
21
M13.9
ICD-10 Finland
Arthritis, unspecified
3.1
7.5
33
116
WX110
NOMESCO Finland
Infiltration anesthesia
2.2
7.5
235
1853
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.5
7.5
54
246
M07.4*K50.9
ICD-10 Finland
Arthropathy in Crohn's disease [regional enteritis]
82.0
7.4
8
*
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
3.6
7.4
25
74
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
4.0
7.4
21
55
ZY010
NOMESCO Finland
Hospital outpatient
3.5
7.3
26
80
R60.9
ICD-10 Finland
Oedema, unspecified
3.5
7.3
26
80
D05BB02
ATC
acitretin; oral
7.6
7.3
16
22
XQ902
NOMESCO Finland
Other photography
16.2
7.3
11
7
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
4.7
7.3
17
38
JHA00
NOMESCO Finland
Anal or perianal incision
8.2
7.2
15
19
QB9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in torso, unspecified
30.8
7.2
9
*
QDA25
NOMESCO Finland
Destruction of lesion of skin of lower limb
30.8
7.2
9
*
M79.3
ICD-10 Finland
Panniculitis, unspecified
30.8
7.2
9
*
Z93
ICD-10 Finland
Artificial opening status
30.8
7.2
9
*
K51.0
ICD-10 Finland
Ulcerative (chronic) pancolitis
20.6
7.2
10
5
QDA10
NOMESCO Finland
Incision of skin of lower limb
20.6
7.2
10
5
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.0
7.2
33
119
E66.01
ICD-10 Finland
Obesity due to excess calories
2.7
7.1
42
173
JFB00
NOMESCO Finland
Partial resection of small intestine
9.1
7.1
14
16
103
Kela drug reimbursment
Diabetes, insulin-treated
2.1
7.1
86
485
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
4.6
7.1
17
39
L04AB02
ATC
infliximab; parenteral
14.2
6.9
11
8
XQ802
NOMESCO Finland
Epicutan test
4.0
6.9
20
53
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.1
6.9
77
421
ZXA10
NOMESCO Finland
Bilateral
2.2
6.8
66
340
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.2
6.7
61
306
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.8
6.7
36
141
Z2221
NOMESCO Finland
Medical doctor
2.0
6.7
94
557
K50
ICD-10 Finland
Crohn disease [regional enteritis]
23.1
6.7
9
*
Z2446
NOMESCO Finland
Social worker
3.0
6.7
31
112
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.1
6.7
74
402
A10BA02
ATC
metformin; oral
2.0
6.7
89
518
R4180
NOMESCO Finland
Podiatric therapy
8.1
6.7
14
18
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.7
6.7
38
154
E000006, ,
ATC
3.0
6.6
30
107
N03AX12
ATC
[U] gabapentin; oral
2.2
6.6
60
301
UJF92
NOMESCO Finland
Capsular endoscopy
7.1
6.6
15
22
A07AA09
ATC
vancomycin; oral
10.4
6.6
12
12
S81.9
ICD-10 Finland
Open wound of lower leg, part unspecified
10.4
6.6
12
12
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.8
6.6
20
55
Z01.8
ICD-10 Finland
Other specified special examinations
2.1
6.6
76
420
L03.0
ICD-10 Finland
Cellulitis of finger and toe
2.7
6.5
36
144
JFF13
NOMESCO Finland
Terminal enterostomy
71.3
6.4
7
*
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.6
6.4
37
151
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
11.4
6.3
11
10
Z3226
NOMESCO Finland
Physiotherapist
2.1
6.3
65
343
Z93.3
ICD-10 Finland
Colostomy status
18.5
6.3
9
5
WX213
NOMESCO Finland
Lower leg blockade
18.5
6.3
9
5
L04AB05
ATC
certolizumab pegol; parenteral
18.5
6.3
9
5
M30.0
ICD-10 Finland
Polyarteritis nodosa
+∞
6.3
6
*
L04AA11
ATC
[U] etanercept
+∞
6.3
6
*
B03BA03
ATC
hydroxocobalamin; parenteral
3.6
6.3
21
62
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
27.3
6.3
8
*
1370
FHL
Colonoscopy, whole colon
27.3
6.3
8
*
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
6.0
6.2
16
28
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.2
6.2
57
287
D02AE01
ATC
carbamide; topical
3.1
6.2
27
94
X59
ICD-10 Finland
Exposure to unspecified factor
2.1
6.2
69
375
A03FA01
ATC
metoclopramide; systemic, rectal
2.0
6.2
81
467
R60.0
ICD-10 Finland
Localized oedema
2.4
6.2
46
212
A10AE05
ATC
insulin detemir; parenteral
3.3
6.2
23
73
S21
ICPC
Skin texture symptom/complaint
2.2
6.1
60
311
SPAT1255
SPAT
Intravenous administration of medicine
3.0
6.0
27
96
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
170
395
8.43
79.37
4.5
2.3
198.27
108.99
ug/g
2.57
160
318
96
186
7.06
50.91
2.0
1.6
—
—
—
0
0
60
88
8.24
40.60
1.6
1.5
0.12
0.05
iu/ml
—
10
15
135
428
4.85
40.13
5.3
3.3
0.79
0.81
mmol/l
1.16
130
406
100
259
5.25
37.84
6.7
3.1
—
—
—
0
0
129
416
4.63
37.07
3.7
2.7
9.95
13.40
umol/l
6.01
123
388
59
94
7.54
36.98
2.1
2.9
0.29
0.74
g/l
0.61
53
81
169
677
4.34
36.00
3.9
2.1
2.90
2.87
mg/l
0.06
159
582
54
83
7.69
34.88
1.9
2.7
0.00
0.06
g/l
0.49
49
75
53
83
7.51
33.62
1.5
2.7
0.00
0.00
g/l
-0.00
48
71
265
1533
6.44
33.21
25.1
9.8
4.70
4.02
e9/l
4.32
245
1345
87
222
5.08
33.13
3.3
2.6
10.60
10.35
g/l
0.17
78
208
169
714
4.05
32.58
5.8
3.1
0.34
0.47
e6/l
0.46
140
506
144
577
3.83
29.34
4.2
2.8
7.76
5.92
e6/l
0.61
136
518
181
847
3.78
29.04
6.0
3.3
30.79
124.22
e6/l
0.62
150
634
43
65
7.53
27.99
2.6
1.5
—
—
—
0
0
30
30
10.98
26.92
1.5
1.3
—
—
—
0
0
54
113
5.59
25.43
2.6
2.2
1.48
1.45
g/l
0.07
45
99
208
1160
3.48
23.47
11.3
6.7
1.19
1.22
mmol/l
4.18
202
1069
57
134
5.00
23.45
2.6
2.1
9.46
5.62
iu/ml
0.47
11
23
41
73
6.33
22.77
1.9
2.8
—
—
—
0
0
220
1284
3.54
22.74
13.7
7.6
1.19
1.22
mmol/l
3.82
190
1111
38
63
6.75
22.61
1.7
1.4
—
—
—
0
0
203
1136
3.34
22.36
20.5
12.5
1.21
1.21
inr
0.01
180
941
40
71
6.33
22.27
1.2
1.3
—
—
—
0
0
92
325
3.62
21.75
11.8
7.0
104.18
104.12
mmol/l
0.05
92
325
79
265
3.67
20.05
9.6
9.9
0.14
1.00
mmol/l
1.07
73
220
31
47
7.23
19.97
1.8
1.3
7.69
1.31
u/ml
0.78
13
16
102
404
3.29
19.90
5.0
3.0
4.87
2.40
e6/l
1.22
59
188
52
133
4.51
19.14
4.8
3.3
23.89
24.33
mmol/l
0.43
52
133
38
75
5.64
18.90
2.4
5.2
32.78
28.86
mg/l
0.29
29
64
38
75
5.64
18.90
2.4
5.2
62.12
50.88
mg/l
0.22
29
65
102
417
3.17
18.72
2.5
2.0
—
—
—
0
0
83
301
3.41
18.55
3.5
3.0
6.55
6.17
umol/l
0.10
73
263
32
55
6.38
18.31
2.5
1.6
—
—
—
0
0
84
311
3.34
18.12
2.4
1.9
—
—
—
0
0
103
434
3.07
17.82
5.0
2.8
0.93
0.88
e6/l
0.10
62
219
80
294
3.33
17.40
2.5
2.0
—
—
—
0
0
30
51
6.41
17.33
1.7
1.2
7.50
3.35
u/ml
0.50
14
23
68
231
3.50
16.71
6.3
3.6
1.61
1.82
mmol/l
0.16
58
200
212
1338
2.90
16.69
5.6
3.1
159.01
103.60
ug/l
1.38
205
1257
219
1417
2.92
16.24
6.4
3.7
0.00
0.00
estimate
-0.00
68
290
133
676
2.71
15.88
3.2
2.8
349.42
335.06
umol/l
0.81
126
602
143
754
2.68
15.86
2.1
1.7
18.92
21.51
nmol/l
1.30
135
630
71
257
3.30
15.71
3.4
2.6
42.31
29.77
u/l
0.78
62
210
33
68
5.32
15.60
2.3
4.8
8.24
3.52
ratio
0.29
13
37
219
1435
2.85
15.52
6.3
3.8
19.40
5.51
estimate
0.31
70
295
162
916
2.63
15.47
4.5
3.3
30.63
30.01
u/l
0.12
156
873
219
1449
2.80
14.97
6.4
3.8
0.00
0.02
estimate
0.80
63
275
47
140
3.78
13.94
2.5
1.6
—
—
—
0
0
108
522
2.65
13.94
3.7
2.7
2.48
2.45
mmol/l
1.64
102
479
38
97
4.33
13.90
1.8
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
29
60
5.23
13.62
4.6
2.6
0.29
0.35
iu/ml
0.44
19
36
180
1116
2.49
13.53
2.9
2.1
90.35
96.82
pmol/l
1.22
123
588
30
65
5.01
13.37
1.4
1.3
—
—
—
0
0
28
58
5.21
13.12
3.2
2.4
1.67
1.91
index
0.09
12
33
19
13
15.48
11.95
1.6
2.1
—
—
—
0
0
54
194
3.17
11.92
4.1
3.9
1.21
1.22
mmol/l
0.48
49
162
120
648
2.40
11.90
5.6
2.2
—
—
—
0
0
192
1270
2.37
11.86
5.7
2.7
—
—
estimate
—
0
0
144
849
2.31
11.58
4.0
2.7
50.16
62.61
u/l
1.47
137
800
21
20
11.18
11.45
1.1
1.1
—
—
—
0
0
22
42
5.57
11.24
1.4
1.3
1112.00
228.00
titre
—
5
5
29
71
4.41
11.14
1.5
1.3
38.07
51.33
u/ml
—
6
9
126
725
2.25
10.50
3.4
3.4
1407.65
1245.92
ng/l
0.23
116
613
38
119
3.50
10.40
1.7
2.5
36.91
40.43
u/l
0.48
33
106
22
47
4.97
9.93
1.3
1.2
—
—
—
0
0
102
557
2.25
9.48
1.4
1.3
22.16
25.86
iu/ml
0.30
31
165
30
88
3.67
9.03
1.5
1.3
4.52
2.41
u/ml
—
6
14
24
60
4.26
8.97
1.3
2.0
—
—
—
0
0
108
621
2.14
8.71
2.4
1.7
1.29
1.14
mg/l
0.27
96
482
59
265
2.52
8.45
4.9
4.5
5.20
9.31
ug/l
0.99
50
218
24
63
4.05
8.42
2.0
1.6
24370.93
17023.09
e6/l
0.17
15
44
113
689
2.01
7.60
1.5
1.3
0.77
1.40
u/ml
1.34
27
192
91
514
2.10
7.53
1.3
1.3
14.71
6.79
u/ml
0.67
32
201
15
18
8.70
7.41
1.5
1.7
353.43
593.50
e6/l
—
7
12
17
38
4.68
7.27
1.5
1.5
—
—
—
0
0
85
482
2.06
6.89
4.1
3.8
294.45
238.23
ng/l
0.08
69
350
19
50
3.99
6.64
1.4
1.3
220.91
196.25
u/ml
0.17
11
24
45
200
2.47
6.54
4.0
2.6
57.50
66.33
ml/min/173m2
0.73
20
87
73
399
2.09
6.49
2.0
1.7
1252.13
1223.50
nmol/l
0.09
56
293
124
817
1.87
6.40
5.6
4.2
10.02
9.33
mg/mmol
0.09
92
496
23
72
3.37
6.28
1.3
1.2
—
—
—
0
0
47
217
2.38
6.28
4.8
3.9
82.32
77.66
ng/l
0.15
41
192
21
62
3.56
6.26
1.5
1.6
—
—
—
0
0
33
129
2.75
6.19
1.6
1.3
—
—
—
0
0
278
2408
2.69
6.19
8.7
6.2
40.74
38.79
mmol/mol
2.39
265
2280
15
26
6.01
5.91
8.3
1.5
33.27
32.73
pg
0.15
15
26
12
15
8.27
5.89
1.3
3.7
769.08
649.60
u/ml
0.17
12
15
84
500
1.94
5.83
2.4
1.8
640.18
39019141.37
pmol/l
0.72
76
428
120
802
1.82
5.79
5.5
3.1
0.00
0.00
estimate
0.50
57
239
17
36
4.94
5.70
1.2
1.2
—
—
—
0
0
15
28
5.58
5.61
1.1
1.4
—
—
—
0
0
18
52
3.62
5.54
1.5
1.6
—
—
—
0
0
117
785
1.79
5.52
2.6
2.1
845.91
186.70
u/l
0.53
110
748
118
796
1.79
5.46
6.4
3.8
0.00
0.00
estimate
-0.00
68
276
282
2494
2.67
5.36
48.3
14.2
85.18
84.17
ml/min/173m2
0.29
271
2301
12
18
6.89
5.30
1.3
1.2
—
—
—
0
0
5
0
+∞
5.22
1.8
0.0
—
—
—
0
0
10
12
8.57
5.10
1.6
2.3
88.30
109.42
%
—
10
12
125
872
1.73
5.06
4.7
3.3
6.61
7.66
mmol/l
1.95
111
740
12
20
6.20
4.96
1.2
1.3
107.67
103.05
pmol/l
0.12
12
20
32
138
2.47
4.95
4.3
3.7
2.17
1.15
mmol/l
1.48
22
102
36
164
2.35
4.95
2.5
3.2
331.42
164.96
ng/l
0.67
31
150
14
30
4.84
4.74
2.7
1.8
88.15
90.85
%
0.85
14
30
9
11
8.39
4.59
1.3
2.0
—
—
—
0
0
145
1075
1.66
4.55
6.0
3.6
0.00
0.01
estimate
0.74
56
240
21
76
2.89
4.55
1.4
1.7
—
—
—
0
0
287
2597
2.69
4.50
52.6
15.1
24.34
22.71
mg/l
0.49
278
2110
22
83
2.78
4.43
2.5
2.0
2.63
5.92
iu/l
1.27
11
33
23
89
2.71
4.42
1.3
1.3
—
—
—
0
0
19
66
3.00
4.42
3.0
2.1
119.00
129.44
g/l
1.19
13
50
14
34
4.26
4.26
1.3
1.6
—
—
—
0
0
22
85
2.71
4.24
1.2
1.4
247.22
318.04
ug/g
—
9
47
22
85
2.71
4.24
1.3
1.2
—
—
—
0
0
14
41
3.53
4.23
1.5
1.7
—
—
—
0
0
9
13
7.10
4.19
1.3
2.0
—
—
—
0
0
9
13
7.10
4.19
1.2
2.5
—
—
—
0
0
9
13
7.10
4.19
1.2
2.5
—
—
—
0
0
8
10
8.18
4.08
1.4
2.1
—
—
—
0
0
17
58
3.04
4.08
2.1
1.3
—
—
—
0
0
7
7
10.20
4.03
1.1
1.7
—
—
—
0
0
131
977
1.60
3.84
4.5
3.8
38.82
33.95
ng/l
0.13
94
660
15
50
3.10
3.74
1.7
1.7
—
—
—
0
0
21
85
2.58
3.72
1.3
1.2
—
—
—
0
0
29
138
2.22
3.63
3.4
2.6
0.61
0.61
%
0.03
29
138
7
9
7.93
3.57
6.0
7.6
—
—
—
0
0
9
17
5.42
3.53
1.4
1.7
—
—
—
0
0
6
6
10.16
3.51
1.0
1.0
—
—
—
0
0
19
76
2.60
3.45
1.6
1.7
—
—
—
0
0
11
29
3.89
3.22
1.4
1.1
—
—
—
0
0
15
55
2.82
3.20
2.3
1.3
168.00
165.78
au/ml
—
5
21
7
11
6.48
3.20
3.6
2.7
0.57
0.73
index
—
7
11
235
2055
1.62
3.15
6.0
4.6
14.79
14.75
pmol/l
0.09
228
1886
28
140
2.10
3.12
3.4
2.6
1.24
1.23
%
0.04
28
140
11
30
3.76
3.12
2.4
2.0
9.70
10.60
mmol/l
0.35
11
30
11
30
3.76
3.12
2.5
3.4
—
—
—
0
0
15
56
2.77
3.10
2.0
2.4
5.59
6.13
pmol/l
0.24
15
56
8
17
4.80
2.94
1.9
4.1
911.13
1023.94
mg
—
8
17
141
1119
1.48
2.89
2.6
2.0
1.50
1.37
mmol/l
0.86
120
957
215
1860
1.52
2.85
4.8
3.3
59.43
43.30
u/l
2.81
205
1775
10
28
3.66
2.81
1.3
1.3
—
—
—
0
0
5
6
8.44
2.76
1.0
1.0
—
—
—
0
0
5
6
8.44
2.76
1.2
3.0
177.20
138.67
%
—
5
6
5
6
8.44
2.76
1.0
1.0
110.40
96.17
%
—
5
6
22
106
2.16
2.70
6.1
9.7
2.23
1.63
%
1.01
22
100
8
19
4.29
2.69
1.5
1.2
—
—
—
0
0
11
35
3.22
2.67
1.5
1.3
—
—
—
0
0
15
61
2.53
2.66
1.1
1.1
1.57
21.21
e6/l
—
7
43
10
30
3.41
2.62
1.3
1.2
—
—
—
0
0
10
30
3.41
2.62
1.2
1.2
—
—
—
0
0
10
30
3.41
2.62
1.3
1.2
—
—
—
0
0
11
36
3.13
2.59
1.4
1.6
—
—
—
0
0
15
62
2.49
2.58
1.3
1.2
17.00
208.09
e6/l
—
8
47
36
213
1.78
2.49
1.2
1.2
195.44
161.45
u/ml
0.17
16
79
12
45
2.73
2.48
1.2
1.2
44.55
17.74
u/l
0.98
12
38
12
46
2.67
2.39
1.3
1.9
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
5
8
6.33
2.38
1.0
1.0
93.60
147.50
%
—
5
8
10
33
3.10
2.38
1.3
1.2
—
—
—
0
0
10
33
3.10
2.38
1.3
1.2
—
—
—
0
0
11
41
2.74
2.23
1.0
1.0
—
—
—
0
0
7
20
3.56
2.06
2.0
2.0
—
—
—
0
0
49
335
1.55
1.98
1.9
1.8
1.75
1.47
%
0.99
44
296
201
1779
1.38
1.90
3.4
3.3
—
—
—
0
0
263
2447
1.53
1.84
7.3
5.5
1.83
1.85
mu/l
0.09
256
2272
5
12
4.22
1.83
1.2
1.0
1552.80
1729.33
miu/ml
—
5
12
26
156
1.73
1.75
1.2
1.3
—
—
—
0
0
5
13
3.89
1.72
1.2
1.0
—
—
—
0
0
15
76
2.02
1.67
1.1
1.1
—
8.88
—
0
12
6
19
3.20
1.67
1.2
1.1
—
—
—
0
0
10
43
2.37
1.60
1.7
1.2
—
—
—
0
0
10
43
2.37
1.60
1.7
1.2
—
—
—
0
0
11
50
2.24
1.59
2.3
2.0
4.28
5.41
mmol/24h
0.59
11
44
21
123
1.76
1.55
1.2
1.4
216.67
262.93
miu/ml
—
6
66
6
21
2.89
1.51
2.3
2.5
—
—
—
0
0
10
45
2.26
1.48
1.8
1.4
31.10
21.71
u/l
—
10
40
21
330
0.61
1.39
2.0
2.0
3.24
3.37
ratio
0.19
16
262
265
2503
1.44
1.36
5.7
4.9
6.17
5.87
mmol/l
2.12
251
2309
18
106
1.74
1.32
2.0
1.6
—
—
—
0
0
6
24
2.53
1.31
1.7
2.0
—
—
—
0
0
30
209
1.48
1.16
1.3
1.4
—
—
—
0
0
12
65
1.88
1.15
1.3
1.2
—
—
—
0
0
25
171
1.50
1.06
1.3
1.3
—
33.09
—
0
11
19
124
1.57
0.99
1.6
1.5
0.56
0.29
mg/l
—
8
55
16
100
1.63
0.99
1.6
1.6
—
—
—
0
0
25
177
1.45
0.92
1.4
1.9
—
—
—
0
0
6
30
2.02
0.87
2.3
1.6
—
—
—
0
0
21
295
0.69
0.86
12.5
6.9
—
—
—
0
0
18
121
1.52
0.85
2.3
2.5
17251.50
4485.82
u/l
—
7
50
29
380
0.74
0.80
2.6
2.1
—
—
—
0
0
0
26
0.00
0.79
0.0
1.2
—
—
—
0
0
256
2454
1.26
0.78
4.6
4.1
1.39
1.27
mmol/l
2.17
245
2265
0
27
0.00
0.78
0.0
1.8
—
7.68
—
0
27
24
176
1.39
0.75
3.5
2.8
40.98
51.29
u/ml
0.16
24
167
27
352
0.74
0.73
2.7
2.0
—
—
—
0
0
268
2588
1.29
0.72
5.6
4.9
4.52
4.69
mmol/l
1.95
257
2423
266
2574
1.26
0.64
5.3
4.8
1.44
1.48
mmol/l
0.92
255
2398
270
2618
1.27
0.63
6.2
5.6
2.59
2.75
mmol/l
2.54
257
2446
69
598
1.20
0.63
1.5
1.6
—
—
—
0
0
29
228
1.30
0.61
1.6
1.9
—
—
—
0
0
42
502
0.81
0.59
3.5
4.5
22.09
22.02
%
0.01
14
231
6
98
0.60
0.53
2.0
1.9
—
—
—
0
0
71
629
1.17
0.51
5.5
3.8
1.02
1.02
kg/l
0.09
53
414
11
155
0.70
0.49
1.1
1.0
—
—
—
0
0
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
10
73
1.38
0.35
2.7
1.8
184.30
233.16
pmol/l
—
10
67
33
372
0.87
0.27
3.2
3.0
0.52
0.75
ug/l
2.09
24
226
12
98
1.23
0.21
2.1
2.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
8
104
0.76
0.21
1.4
1.4
—
—
—
0
0
48
516
0.92
0.18
1.8
1.5
—
—
—
0
0
7
61
1.15
0.17
1.4
1.5
54.04
49.50
ug/l
—
7
61
6
77
0.77
0.16
2.3
1.7
—
—
—
0
0
11
94
1.18
0.13
2.0
1.8
—
—
—
0
0
5
45
1.11
0.10
1.0
1.2
—
—
—
0
0
6
74
0.81
0.07
1.8
1.7
—
—
—
0
0
8
93
0.86
0.07
1.5
1.3
—
—
—
0
0
223
2220
1.02
0.02
60.8
19.4
327.54
332.27
g/l
10.44
223
2212
15
147
1.02
0.00
1.5
1.4
32.59
25.43
iu/l
—
9
125
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
98.57
—
0
7
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
51
0.98
-0.00
2.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
63
630
1.00
-0.00
4.3
5.2
1.57
1.98
ug/l
0.60
56
557
0
7
0.00
-0.00
0.0
1.1
—
1.30
—
0
7
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: L12_PG – Pyoderma gangrenosum
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).